Kumar S, Harrison S, Cavo M, et al. A phase 3 study of venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. 24th Congress of EHA, abstract LB2601.
Grote verschillen tussen landen in toegang tot nieuwe medicatie
mrt 2024 | Borstkanker, Dermato-oncologie, Gynaecologische oncologie, Leukemie, Longoncologie, Uro-oncologie